The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Shares close at HK$96 versus HK$71.88 offer, outperforming recent large Hong Kong listings amid strong AI-driven demand.
A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations ...
Crosetto Foundation calls for transparency at the 2026 Total Body PET Conference to evaluate technology capable of detecting early-stage cancer currently missed by existing systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results